High concentrations of polymyxin B inhibited the growth of Candida albicans and Saccharomyces cerevisiae. When these yeasts were incubated with concentrations of polymyxin B too low to affect growth, and were then exposed to tetracycline, protein synthesis was inhibited and at least 99% of the organisms were killed. Neither inhibition of protein synthesis nor cell death occurred in cultures treated with high concentrations of tetracycline alone. We conclude that polymyxin B at high concentrations affects the cell membrane of yeasts, which results in inhibition of growth. At low concentrations, it increases the permeability of the yeast cell membrane to tetracycline, which then inhibits protein synthesis and leads to cell death.
Polymyxin B is a surface-active bactericidal antibiotic which alters the permeability of the bacterial cell envelope by binding to the negatively charged phospholipid component of the membrane and causing cell lysis (4) . Because eukaryotic cells also contain phospholipids in their cell membranes (7) , it was reasonable to expect that polymyxin B would disrupt permeability barriers in them as well. Two previous studies have shown this to be true in a protozoan (6) and in the yeast Candida tropicalis (5) . The latter study, however, failed to demonstrate a polymyxin B effect in a variety of other yeasts.
Several agents have been shown to be ineffective against yeasts because of failure to penetrate the cytoplasmic membrane and gain access to their site of action. For example, tetracycline has been shown to inhibit protein synthesis in extracts of yeasts (1) Synergism studies. The susceptibility of each organism to polymyxin B and tetracycline was determined by the broth-dilution method, as previously described (2) . A wide range of antibiotic concentrations was examined for each organism, and cell viability was determined by colony counts after 1, 2, 3, and 7 days of incubation. The minimal inhibitory concentration (MIC) was defined as the lowest concentration of drug required to inhibit completely the growth of the organism over the designated time interval.
Synergism was also determined by colony counts of each organism in the presence of the antibiotics used singly and in combination. Exposure to the two drugs was done either by 24-hr pretreatment of the yeasts with polymyxin B or by simultaneous addition of the polymyxin B and tetracycline. Our definition of antifungal drug synergy was a decrease of 100-fold or more in colony counts caused by the drugs in combination as compared with the counts when the drugs were used singly (3). The level of each antibiotic used in the combined drug studies was well below the respective MIC. In the MIC and synergism studies, a standard inoculum of 5 Synergy was demonstrated by a decrease of colony counts in both yeasts with a combination of drugs at concentrations which exhibited little or no antifungal activity when employed singly ( Fig. 3A and B) . Tetracycline alone had no effect on growth of either S. cerevisiae MG456 or C. albicans 374 at concentrations as high as 500 ,ug/ml. For polymyxin B, the concentrations used in combination with tetracycline were less than half the MIC. For C. albicans, the MIC at 3 days was 30 ,ug/ml; for S. cerevisiae, it was 6.0 jug/ml (Fig. 1) ences in their cell membranes. Newton has observed the antibacterial activity of polymyxin B to be most potent against gram-negative organisms and has suggested that a difference in membrane phospholipid content accounted for this selectivity (4) . Varying susceptibilities within the genus Candida have also been explained by a similar mechanism (5). The increase in MIC that we have observed on prolonged incubation may result from selection of resistant organisms, or it may reflect inactivation of the drug over prolonged time periods.
Nicholls was unable to demonstrate any polymyxin B effect in the 45 clinical isolates of C. albicans that he examined, whereas each of 12 C. tropicalis strains studied was susceptible to the drug (5). In determining susceptibility to polymyxin B, the culture media and techniques must be sufficient to insure optimal growth conditions. In studies with blue-green algae, Whitton showed that polymyxin B was most effective against actively growing, as opposed to older, cell cultures, and postulated that polymyxin B function required a functional, metabolizing cell (8) . We preincubated our yeasts overnight prior to use in these investigations, whereas The strong reduction in viability of the yeasts with the use of the two drugs in combination resulted from the potentiation of tetracycline by polymyxin B. This conclusion is supported by the data which showed that the drug combination specifically affected protein synthesis and not RNA synthesis. If, instead, tetracycline were potentiating polymyxin B, the pattern of cell death would have conformed to that seen for excess polymyxin B ( Fig. 2A and B) . Studies with polymyxin B on bacteria have confirmed the ability of this agent to break down permeability barriers and allow materials to flow into the cell. N-tolyl-2-naphthylamine-8-sulfonic acid (TNS), a fluorescent dye which is detectable only when combined with protein, was nonfluorescent when exposed to polymyxin B or to bacteria. When polymyxin B was added to the bacteria which had been treated with TNS, fluorescence was detected, indicating the uptake of the dye and its binding to proteins within the cell (4) .
The antagonism between polymyxin B and tetracycline when added simultaneously is best viewed with regard to the ionic properties of polymyxin B. Polymyxin B has been shown to react with any of a number of acidic substances
